Pfizer reported another quarter of huge revenues growth because of its COVID-19 vaccine on Tuesday, but lowered the company's full-year profit forecast due in part to shifts in foreign exchange.
The major American drugmaker reported revenues of $25.7 billion for the first quarter, up 77 percent from the year-ago period, with the COVID vaccine taking in $13.2 billion.
Net income jumped 61% to $7.9 billion.
More HERE